Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
W. Brian Gibler, MD, FACEP, FACC, FAHA
Stuart Connolly, MD, FRCPC
Rhonda Cadena, MD, FNCS, FCCM
Greg Albers, MD
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
Adrian R. Parry-Jones, FRCP, PhD
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Andrew Wilner, MD, FACP, FAAN
Marcus E. Peter, PhD
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
Ashley Baker, MSN, PMHNP
Morris Goldman, MD
Dara Sanandaji
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
George Bloom, PhD
A Successful and Safe Stem Cell Therapy for Progressive MS
Charles Turck, PharmD, BCPS, BCCCP
Stefano Pluchino, MD, PhD
New Study Shows EBV-Specific T-Cells Contribute to MS Development
J. William Lindsey
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Marc Haut, PhD
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
Hannah Brown, MD
Which Comes First? The Stimulant or the Oxybate?
Matthew Davis, MD
Alcibiades J. Rodriguez, MD, FAASM
Are Oxybates Safe in Narcolepsy Patients?
Kevin Trice, MD
Ana C. Krieger, MD
Practical Approach to Incorporation of Oxybates Into Clinical Practice
Evaluating and Promoting Health in Idiopathic Hypersomnia: Beyond Sleepy
Logan Schneider, MD
Life’s Essential 8: Healthy Sleep With Narcolepsy
Lee Surkin, MD, FACC, FCCP, FASNC, FAASM
Professional Recommendations of Clinically Validated Tools Used to Monitor Response to Treatment in Idiopathic Hypersomnia
Patient Testimonial: A Day In the Life of an Idiopathic Hypersomnia Patient
Diana Kimmel
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.